News
Current position:Product Center > Cell lines > Kinase > EGFR > H_EGFR(L858R-T790M) BAF3 Cell Line
H_EGFR(L858R-T790M) BAF3 Cell Line
Description
Cat. No: GM-C28271
Product: H_EGFR(L858R-T790M) BAF3 Cell Line


EGFR is a member of the receptor tyrosine kinase (TK) family, widely distributed on the surface of mammalian fibroblasts, epithelial cells, and other cell types. The EGFR signaling pathway plays a crucial role in physiological processes such as cell proliferation and differentiation. When EGFR undergoes mutations, it can result in the continuous activation of the EGFR signaling pathway even in the absence of ligand binding, leading to abnormal cell proliferation. EGFR mutations have been identified in various tumors, including non-small cell lung cancer, breast cancer, colorectal cancer, and head and neck squamous cell carcinoma (HNSCC). Several tyrosine kinase inhibitors (TKIs) target EGFR mutations, such as Afatinib, Erlotinib, Gefitinib, Osimertinib (AZD 9291), and Cetuximab.

BA/F3 cells are interleukin-3 (IL-3)-dependent precursor B cells; certain protein kinases can substitute for IL-3 to promote the growth of BA/F3 cells in a dependent manner. By using inhibitors to antagonize this effect, this system can be employed for research on kinase inhibitors.

H_EGFR(L858R-T790M)BAF3 Cell Line is a clonal stable BaF3 cell line constructed using lentiviral technology, constitutive expression of the EGFR gene. Can be used for the development and validation of small molecule drugs targeting EGFR.
Data
Cell proliferation assay. H_EGFR(L858R-T790M) BAF3 Cell Line (Cat. GM-C28271) at a concentration of 1E4 cells/well (96-well format) was treated with serial dilutions of Osimertinib (AZD9291) (Selleck/S7297), Erlotinib (OSI-774) (Selleck/S7786), Afatinib (BIBW2992) (Selleck/S1011) in assay buffer (RPMI 1640 + 10% FBS + 1% P.S) for 72 hours. The firefly luciferase activity was measured using the GMTiter™ Luminescent Cell Viability Assay (Cat. GM-040504).
The protein expression levels of Human EGFR(L858R-T790M) in the H_EGFR(L858R-T790M)BAF3 Cell Line (Cat. GM-C28271) were determined by Western blotting (WB).
The EGFR mutation analysis by Sanger sequencing.
Specifications
Cat. NoGM-C28271
ProductH_EGFR(L858R-T790M)BAF3 Cell Line
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumRPMI 1640+10% FBS+1% P.S
Growth mediumRPMI 1640+10% FBS+1% P.S+0.25 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesSuspension
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
RPMI 1640VivaCell/C3010-0500
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
PuromycinGenomeditech/GM-040401
Osimertinib (AZD9291)Selleck.cn/S7297
Erlotinib (OSI-774)Selleck.cn/S7786
Afatinib (BIBW2992)Selleck.cn/S1011
Recombinant Anti-EGFR Antibody [E235]Abcam/ab32077
CellTiter-Glo Luminescent Cell Viability AssayPromega/G7572
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes.Discard supernatant.

d)       Resuspend cell pellet with the recommended complete medium. And dispense the suspension into 1-2 T-25 culture flasks.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vials in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+0.25 μg/mL Puromycin

Approximately 48-72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics. If cells are not passaged within 48 hours, it is recommended to add some fresh recovery medium and place the flask horizontally.

a)          When the cell density reaches 1 - 1.2E6 cells/mL, subculture the cells. Do not allow the cell density to exceed 1.4E6 cells/mL.

b)         It is recommended to use T-25 flasks for subculturing.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 3E5 and 1E6 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          These cells are sensitive to density, so please ensure that the cell density is maintained within an appropriate range during culture and subculturing.

b)         During the first passage, pay attention to the nutrient supply; if not subculturing, make sure to add fresh recovery medium every other day as needed.


Current Position:Product Center > Cell lines > Kinase > EGFR > H_EGFR(L858R-T790M) BAF3 Cell Line
classify
H_EGFR(L858R-T790M) BAF3 Cell Line
Description
Cat. No: GM-C28271
Product: H_EGFR(L858R-T790M) BAF3 Cell Line


EGFR is a member of the receptor tyrosine kinase (TK) family, widely distributed on the surface of mammalian fibroblasts, epithelial cells, and other cell types. The EGFR signaling pathway plays a crucial role in physiological processes such as cell proliferation and differentiation. When EGFR undergoes mutations, it can result in the continuous activation of the EGFR signaling pathway even in the absence of ligand binding, leading to abnormal cell proliferation. EGFR mutations have been identified in various tumors, including non-small cell lung cancer, breast cancer, colorectal cancer, and head and neck squamous cell carcinoma (HNSCC). Several tyrosine kinase inhibitors (TKIs) target EGFR mutations, such as Afatinib, Erlotinib, Gefitinib, Osimertinib (AZD 9291), and Cetuximab.

BA/F3 cells are interleukin-3 (IL-3)-dependent precursor B cells; certain protein kinases can substitute for IL-3 to promote the growth of BA/F3 cells in a dependent manner. By using inhibitors to antagonize this effect, this system can be employed for research on kinase inhibitors.

H_EGFR(L858R-T790M)BAF3 Cell Line is a clonal stable BaF3 cell line constructed using lentiviral technology, constitutive expression of the EGFR gene. Can be used for the development and validation of small molecule drugs targeting EGFR.
Data
Cell proliferation assay. H_EGFR(L858R-T790M) BAF3 Cell Line (Cat. GM-C28271) at a concentration of 1E4 cells/well (96-well format) was treated with serial dilutions of Osimertinib (AZD9291) (Selleck/S7297), Erlotinib (OSI-774) (Selleck/S7786), Afatinib (BIBW2992) (Selleck/S1011) in assay buffer (RPMI 1640 + 10% FBS + 1% P.S) for 72 hours. The firefly luciferase activity was measured using the GMTiter™ Luminescent Cell Viability Assay (Cat. GM-040504).
The protein expression levels of Human EGFR(L858R-T790M) in the H_EGFR(L858R-T790M)BAF3 Cell Line (Cat. GM-C28271) were determined by Western blotting (WB).
The EGFR mutation analysis by Sanger sequencing.
Specifications
Cat. NoGM-C28271
ProductH_EGFR(L858R-T790M)BAF3 Cell Line
Product Format1 vial of frozen cells
Quantity5E6 Cells per vial,1 mL
Storage ConditionsLiquid nitrogen immediately upon receipt
Recovery MediumRPMI 1640+10% FBS+1% P.S
Growth mediumRPMI 1640+10% FBS+1% P.S+0.25 μg/mL Puromycin
NoteNone
Freezing Medium90% FBS+10% DMSO
Growth propertiesSuspension
Growth Conditions37°C, 5% CO₂
Safety considerationsBiosafety Level 2
Mycoplasma TestingThe cell line has been screened to confirm the absence of Mycoplasma species.
Materials
ReagentOrdering Information
RPMI 1640VivaCell/C3010-0500
Fetal Bovine SerumCegrogen biotech/A0500-3010
Pen/StrepThermo/15140-122
PuromycinGenomeditech/GM-040401
Osimertinib (AZD9291)Selleck.cn/S7297
Erlotinib (OSI-774)Selleck.cn/S7786
Afatinib (BIBW2992)Selleck.cn/S1011
Recombinant Anti-EGFR Antibody [E235]Abcam/ab32077
CellTiter-Glo Luminescent Cell Viability AssayPromega/G7572
Cell Culture

Cell Recovery

Recovery Medium: RPMI 1640+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium. And spin at approximately 176 x g for 5 minutes.Discard supernatant.

d)       Resuspend cell pellet with the recommended complete medium. And dispense the suspension into 1-2 T-25 culture flasks.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vials in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: RPMI 1640+10% FBS+1% P.S+0.25 μg/mL Puromycin

Approximately 48-72 hours after the initial thawing, the cells can be passaged for the first time. After this initial passage, the culture medium can be adjusted to growth medium supplemented with antibiotics. If cells are not passaged within 48 hours, it is recommended to add some fresh recovery medium and place the flask horizontally.

a)          When the cell density reaches 1 - 1.2E6 cells/mL, subculture the cells. Do not allow the cell density to exceed 1.4E6 cells/mL.

b)         It is recommended to use T-25 flasks for subculturing.

c)          These cells are suspension cells, and it is recommended to use the "half-medium change" method to maintain optimal cell conditions during passaging.

d)         During passaging, you can directly add fresh growth medium to the culture flask, gently pipette to resuspend the cells, and then transfer the cell suspension to a new T-25 flask for continued culture.

Subcultivation Ratio: Maintain cultures at a cell concentraion between 3E5 and 1E6 viable cells/mL.

Medium Renewal: Every 2 to 3 days

Notes

a)          These cells are sensitive to density, so please ensure that the cell density is maintained within an appropriate range during culture and subculturing.

b)         During the first passage, pay attention to the nutrient supply; if not subculturing, make sure to add fresh recovery medium every other day as needed.


Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit